These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8501418)
1. Deficiency of erythropoietin is not responsible for the anaemia associated with cyclosporin treatment of insulin-dependent diabetes mellitus. Canadian-European Randomized Control Trial Group. Nielsen OJ; Mandrup-Poulsen T; Nerup J J Intern Med; 1993 Jun; 233(6):471-6. PubMed ID: 8501418 [TBL] [Abstract][Full Text] [Related]
2. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function. Nampoory MR; Johny KV; al-Hilali N; Seshadri MS; Kanagasabhapathy AS Nephrol Dial Transplant; 1996 Jan; 11(1):177-81. PubMed ID: 8649630 [TBL] [Abstract][Full Text] [Related]
3. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study]. Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. Bosman DR; Osborne CA; Marsden JT; Macdougall IC; Gardner WN; Watkins PJ Diabet Med; 2002 Jan; 19(1):65-9. PubMed ID: 11869305 [TBL] [Abstract][Full Text] [Related]
5. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group. BMJ; 1990 Mar; 300(6724):573-8. PubMed ID: 2108751 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus. Mojiminiyi OA; Abdella NA; Zaki MY; El Gebely SA; Mohamedi HM; Aldhahi WA Diabet Med; 2006 Aug; 23(8):839-44. PubMed ID: 16911620 [TBL] [Abstract][Full Text] [Related]
13. Effect of cyclosporine A on serum tumor necrosis factor alpha in new-onset type I (insulin-dependent) diabetes mellitus. Burke GW; Cirocco R; Markou M; Agramonte RF; Rabinovitch A; Miller J; Skyler JS J Diabetes Complications; 1994; 8(1):40-4. PubMed ID: 8167386 [TBL] [Abstract][Full Text] [Related]
14. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group. Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302 [TBL] [Abstract][Full Text] [Related]
15. Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Voulgarelis M; Kokori SI; Ioannidis JP; Tzioufas AG; Kyriaki D; Moutsopoulos HM Ann Rheum Dis; 2000 Mar; 59(3):217-22. PubMed ID: 10700431 [TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A treatment of young children with newly-diagnosed type 1 (insulin-dependent) diabetes mellitus. London Diabetes Study Group. Jenner M; Bradish G; Stiller C; Atkison P Diabetologia; 1992 Sep; 35(9):884-8. PubMed ID: 1397785 [TBL] [Abstract][Full Text] [Related]
17. Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment. Van Vlerken LG; Van Soest H; Janssen MP; Boland GJ; Drenth JP; Burger DM; Siersema PD; Van Erpecum KJ Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1308-15. PubMed ID: 20729740 [TBL] [Abstract][Full Text] [Related]
18. Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects. Martin S; Schernthaner G; Nerup J; Gries FA; Koivisto VA; Dupré J; Standl E; Hamet P; McArthur R; Tan MH Diabetologia; 1991 Jun; 34(6):429-34. PubMed ID: 1884902 [TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial. Peeters HR; Jongen-Lavrencic M; Vreugdenhil G; Swaak AJ Ann Rheum Dis; 1996 Oct; 55(10):739-44. PubMed ID: 8984939 [TBL] [Abstract][Full Text] [Related]